TSX closed
Loading marketsโ€ฆ

Advertisement

Stocks

Why TelyRx Holdings Inc. stock is sliding today

By Wealth Awesome -

This move is archived. Current quotes and coverage live on the stock page.

Stocks & ETFs:TELY.TO

Get TELY alerts:

Photos provided by Pexels

TelyRx Holdings Inc. faces a challenging day on the TSX, with its stock price down 2.08%.

TelyRx Holdings Inc. (TELY.TO) is experiencing a downturn, closing at CA$2.35 after a 2.08% decline in the last trading session. This drop comes amidst recent financial results that show revenue growth but also highlight ongoing losses.

Advertisement

TelyRx Holdings Inc.

TELY.TO

Full stock page โ†’

TELY.TO

TelyRx Holdings Inc.

Source:WealthAwesomeWealthAwesome
โ†“ $0.95 (-27.14%)
98 day period
$2.20$2.85$3.50Apr 8Jun 18Aug 27

Market cap

$67.81M

52W high

$4.25

52W low

$2.00

1W change

-1.92%

Analyst Price Targets

Based on analyst covering TELY

๐Ÿ“ˆ

Wall Street analysts forecast TELY stock price to rise 135.3% over the next 12 months.

Consensus

Bullish

Based on avg. target vs last close (formal rating unavailable for Canadian listings)

Avg. Target

C$6.00

+135.3% Upside

Current Price

C$2.55

Last close

Compare analyst targets across the TSX & TSXV โ†’

Analyst ratings and price targets are updated periodically. Not financial advice.

Wealth Awesome Price Forecast

WA Model

Statistical 90-day price range based on TELY's historical volatility

HistoricalForecast68%95%
C$0.70C$2.22C$3.74C$5.26C$6.78C$8.31TodayApr 20Jun 24Aug 27Oct 9Nov 22Jan 4

30-Day Vol

101.1%

Annualized

90-Day Vol

99.3%

Annualized

Trend (90d)

-16.2%

Annualized drift

90d Mean

C$2.41

Expected price

HorizonExpected68% Range (1ฯƒ)
30 trading daysC$2.50C$1.76 โ€“ C$3.55
60 trading daysC$2.45C$1.50 โ€“ C$4.02
90 trading daysC$2.41C$1.32 โ€“ C$4.41

Methodology: Range is calculated using 30-day realized volatility via geometric Brownian motion (log-normal model). 68% band = ยฑ1ฯƒ, 95% band = ยฑ2ฯƒ. This is a statistical model, not a prediction. Past volatility does not guarantee future results. Not financial advice.

Advertisement

Investor takeaway: Investors should remain cautious as TelyRx continues to grapple with substantial net losses despite increasing revenues, indicating potential volatility ahead.

TelyRx Holdings Inc. down 2.08% today

Despite growing revenues, TelyRx's increasing net losses signal potential challenges in achieving profitability.

Bull case

TelyRx has shown impressive revenue growth, reporting CA$19.4 million for Q1 2026, a significant increase from previous quarters. If the company can stabilize its financials, this growth trajectory could attract future investments.

Bear case

The company reported a net loss of CA$4.7 million in Q1 2026, which is an increase from the previous quarter. Such losses raise concerns about sustainability and profitability, which could deter investors.

Recent Performance Overview

Advertisement

TelyRx Holdings Inc. closed at CA$2.35, down 2.08% in the last trading session. This decline reflects investor concerns regarding the company's ability to turn its growing revenues into profits. The market cap currently stands at approximately CA$63.5 million, indicating a volatile trading environment.

Financial Results Highlight Ongoing Challenges

In its recent Q1 2026 report, TelyRx announced a revenue increase to CA$19.4 million, up from CA$14.3 million in the previous quarter. However, the net loss widened to CA$4.7 million, raising red flags for investors. The company has yet to demonstrate a clear path to profitability, which could affect future stock performance. For more details, check out the full financial results.

Market Sentiment and Future Outlook

The market reaction to TelyRx's financials suggests a cautious sentiment among investors. With a lack of positive news and ongoing losses, TelyRx's stock may continue to face pressure. Investors should monitor upcoming earnings reports closely for signs of improvement or further decline. For additional insights, visit our stock page.

Advertisement

Wealth Awesome
Written by

Wealth Awesome

Timely coverage of Canadian stocks, earnings, dividends, and market movers for DIY investors. Stories are checked against exchange data and public filings.

View Full Profile โ†’

โœ… Reviewed by Certified Financial Professionals

This content has been reviewed by CFAยฎ charterholders and Certified Financial Planners (CFPยฎ) with over a decade of experience in Canadian financial markets. All information is fact-checked against official Canadian sources and regulations.

Why these credentials matter: CFAยฎ charterholders complete 900+ hours of rigorous study in investment analysis and ethics. CFPยฎ professionals are held to the highest standards of financial planning competency and fiduciary duty in Canada.

๐Ÿ“Š Data AccuracyVerified sources
๐Ÿ‡จ๐Ÿ‡ฆ Canadian FocusLocal expertise
๐Ÿ” Fact-CheckedEditorial review

โš ๏ธ Professional Disclaimer

This content is for educational purposes only and should not be considered personalized financial advice. While our team brings professional expertise, individual circumstances vary. For personalized guidance, consult with a qualified financial advisor, tax professional, or mortgage specialist.

Published: July 3, 2026
Last Updated: July 3, 2026
PARTNER SPOTLIGHT

Blue Cross Lifeยฎ Term Life Insurance

Affordable term life coverage in Canada โ€” get a free quote in seconds, no credit card required.

  • โœ“Coverage from $100,000 to $5 million, terms of 10โ€“30 years
  • โœ“10% off first-year premiums when couples apply together
  • โœ“Fully digital application โ€” many qualify without a medical exam

Sponsored links

Advertisement